Telix Pharmaceuticals Ltd
TLX101-Px
glioma
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on TLX101-Px for glioma is expected Date TBD.
Primary source
· SEC 6-K
verified 11h ago
“Telix has submitted a MAA in Europe covering commercially significant markets, seeking to expand patient access to advanced brain imaging.”